Sanofi SA at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 02:10PM GMT
Mark Douglas Purcell - Morgan Stanley, Research Division - Equity Analyst

Okay. Let's get started. My name is Mark Purcell. I'm one of the European pharmaceutical analyst here at Morgan Stanley (inaudible), my esteemed colleague next to me as well. And we have the pleasure to have Sanofi, Dietmar. Thanks so much for joining us again. And before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to Morgan Stanley sales representative.

Questions and Answers:

Mark Douglas Purcell - Morgan Stanley, Research Division - Equity Analyst

So Dietmar, thanks so much for joining us again. We really appreciate it. We saw a press release today, you've got an R&D Day on the 7th of December. So we don't have still your thunder, but we want to get your insights into what to -- how to think as we close out the year. But I guess at a sort of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot